Update: OncoGenex Pharmaceuticals (OGXI)

Editor’s note: Addition to February 17’s Daily Alert on OncoGenex Pharmaceuticals (OGXI) Editor Vivian Lewis asked that I add an important note: Teva Pharma, the Israeli generics giant looking for a new mission in life, has financed the phase III trials of OncoGenix custirsen with...
Read More

Investment Digest Top Picks from 2013 — A-D

It’s time for a look-back at our Top Picks from 2013—a year in which our contributors averaged a 31.27% return. I’ve broken the updates down alphabetically—into digestible sections—so that you can easily find the stocks in which you are interested. In each of alerts,...
Read More

Dividend Digest Top Picks from 2013 — A-D

It’s time for a look-back at our Top Picks from 2013—a year that saw some very nice returns. I’ve broken the updates down alphabetically—into digestible sections—so that you can easily find the stocks in which you are interested. In each of the alerts, included...
Read More

A2A SpA (AEMMY or A2A)

In today’s Daily Alert, Global Investing Editor Vivian Lewis recommends a deeply undervalued Italian utility. This stock pays fairly irregular dividends (and just went ex-dividend last month) and may be tricky to buy in the U.S., but Lewis argues that long-term holders will well...
Read More

Herzfeld Caribbean Basin Fund (CUBA)

In today’s Daily Alert,Global Investing Editor Vivian Lewis recommends a closed-end fund (CEF) that invests in the Caribbean and pays an annual dividend for a current yield of about 2.24%. “Herzfeld Caribbean Basin Fund (CUBA $9 Nasdaq), run by closed-end fund expert Tom Herzfeld, is buy...
Read More

Follow-Up: Seadrill Ltd. (SDRL)

In today’s Daily Alert, Global Investing Editor Vivian Lewis recommends selling a high-yielding Top Pick from 2011. SDRL was recommended by Global Investing as a Top Pick for 2011 at $33.92 in Investment Digest issue 687, dated January 19, 2013. “We are selling Seadrill Ltd. $40)...
Read More

Aberdeen Asia Pacific Income Fund, Inc. (FAX)

Global Investing Editor Vivian Lewis chose the second- best performing Top Pick of 2012, an RBS preferred stock. “Aberdeen Asset Management owns some jewels. I support one of the shares from its stable, Aberdeen Asia Pacific Income Fund, Inc. (FAX – yield 5.30%), yield...
Read More

Top Picks 2012 Updates Part 3

Today’s Daily Alert features updates on the 2012 Top Picks that begin with letters L through R. L Up 75%, Lennar Corp. (LEN, $39) was the second-best performing Top Pick this year. LEN was recommended by Cabot Market Letter Editor Michael Cintolo. Investment Digest subscribers advised...
Read More

The Best Dividend Stock Picks of 2012

On Tuesday, I announced the best-performing Investment Digest Top Picks from 2012 (if you missed the issue and are curious, you can read it online here.) Today, I’m sharing the winning Dividend Digest selections. But since most of our subscribers are looking for when...
Read More

Follow-Up: Xinyuan Real Estate Corp. (XIN)

XIN was recommended by Global Investing at $4.10 in Investment Digest issue 665, dated February 17, 2010. Editor Vivian Lewis sold XIN yesterday, writing in part: "The U.S. SEC has blocked stock accounts in Hong Kong while it is looking into the CNOOC insiders who traded Nexen stock the...
Read More